Skip to search formSkip to main contentSkip to account menu

ameltolide

Known as: 4-amino-N-(2,6-dimethylphenyl)benzamide 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
The anticonvulsant ameltolide (LY201116) is a novel potential therapy for the treatment of canine epilepsy. Eight dogs were… 
1998
1998
Fifteen compounds related to ameltolide (LY 201116) were studied for (i) anticonvulsant potential in the maximal electroshock… 
1995
1995
1992
1992
Summary: The newly characterized anticonvulsant ameltolide was studied in mice in combination with the standard antiepileptic… 
1991
1991
The 4-aminobenzamides have provided several anticonvulsants that have been extensively investigated. Ameltolide, 4-amino-N-(2,6… 
1991
1991
Ameltolide, a novel anticonvulsant agent, has been shown in animal models to be effective in controlling seizures. The… 
1988
1988
The anticonvulsant and toxic properties of 4-amino-N-(2,6-dimethylphenyl)benzamide, (ADD 75073), were compared with phenytoin… 
1988
1988
Summary: The anticonvulsant and toxic properties of 4‐amino‐N‐(2,6‐dimethylphenyl)benzamide, (ADD 75073), were compared with… 
1988
1988
Summary: LY201116 [4‐amino‐N‐(2,6‐dimethylphe‐nyl)benzamide], an effective anticonvulsant in several animal models, is rapidly… 
1987
1987
Compound 2 [4-amino-N-(2,6-dimethylphenyl)benzamide] is an effective anticonvulsant in several animal models. For example…